Fifth, recent evidence suggests that many splicing defects and symptoms of DM1 are triggered when the last remaining fraction of MBNL protein is titrated from the nucleoplasm and sequestered in foci (18,61), which implies that partial release of MBNL protein may be all that is required to improve splicing regulation. The gene discussed is MBNL1; the disease is myotonic dystrophy type 1.